Prediabetes Deserves More Attention: A Review
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Evidence increasingly demonstrates that prediabetes is a toxic state, as well as a risk factor for diabetes, and is associated with pathophysiological changes in several tissues and organs. Unfortunately, use of available evidence-based treatments for prediabetes is low. This review seeks to explain why prediabetes must be viewed and treated as a serious pathological entity in its own right. It offers an overview of the pathophysiology and complications of prediabetes and describes how this condition can be reversed if all treatment avenues are deployed early in its course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“not only because of the association between prediabetes and cardiovascular risk but also because of the opportunity to improve cardiovascular outcomes through appropriate weight management.”
From Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Unwin, N. C. (2006) · Cited by 1,661
Huang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016) · BMJ · doi:10.1136/bmj.i5953 · Cited by 1,012 · cited 1×
“(26) concluded that IFG, IGT, and prediabetes (by the ADA A1C criterion) are independently associated with an increased risk of composite cardiovascular events, coronary heart disease, stroke, and all-cause mortality.”
BackgroundHuman Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., Chen, Y., & Ji, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071108 · Cited by 946
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Punthakee, Z., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.003 · Cited by 877
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Goldenberg, R., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.011 · Cited by 611
Aberrant intestinal microbiota in individuals with prediabetes
the IMI-DIRECT consortium, Allin, K. H., Tremaroli, V., Caesar, R., Jensen, B. A. H., Damgaard, M. T. F., Bahl, M. I., Licht, T. R., Hansen, T. H., Nielsen, T., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4550-1 · Cited by 460 · cited 2×
“(65) demonstrated intestinal dysbiosis characterized by depletion of the genus Clostridium and the mucin-degrading bacterium Akkermansia muciniphila.”
BackgroundResultDiabetes Prevention Program Research Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02043.x · Cited by 363
Prediabetes and Cardiovascular Disease
Brannick, B., & Dagogo-Jack, S. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.001 · Cited by 293 · cited 5×
“barriers, and increased ECM component interaction with cell surface receptors (5,7).”
BackgroundInfluential
Cited by
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307563 · Cited by 3,236
Yousef, H., Khandoker, A. H., Feng, S. F., Helf, C., & Jelinek, H. F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1173402 · Cited by 76
Worldwide trends in prediabetes from 1985 to 2022: A bibliometric analysis using bibliometrix R-tool
Zhao, J., & Li, M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1072521 · Cited by 69
Atherosclerosis and Insulin Resistance: Is There a Link Between Them?
Brie, A. D., Christodorescu, R., Popescu, R., Adam, O., Tîrziu, A., & Brie, D. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061291 · Cited by 58
Cao, Z., Li, W., Wen, C. P., Li, S., Chen, C., Jia, Q., Li, W., Zhang, W., Tu, H., & Wu, X. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4989 · Cited by 40
Ruiz‐Pozo, V. A., Guevara‐Ramírez, P., Paz‐Cruz, E., Tamayo‐Trujillo, R., Cadena-Ullauri, S., Frías-Toral, E., Simancas‐Racines, D., Roshkova, Y. V. A., Reytor-González, C., & Zambrano, A. K. (2024) · Food and Agricultural Immunology · doi:10.1080/09540105.2024.2398042 · Cited by 30
“In some cases, bariatric surgery has been used to reduce blood glucose concentration (Lawal et al., 2020).”
Roles of hydroxyeicosatetraenoic acids in diabetes (HETEs and diabetes)
Dong, L., Wang, H., Chen, K., & Li, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113981 · Cited by 28
Zaromytidou, E., Koufakis, T., Dimakopoulos, G., Drivakou, D., Konstantinidou, S., Rakitzi, P., Grammatiki, M., Manthou, E., Νοτόπουλος, Α., Iakovou, I. P., et al. (2022) · Metabolites · doi:10.3390/metabo12100884 · Cited by 24
“Prediabetes represents an important public health concern, not only because it significantly increases the risk of progression to diabetes, but also because it has been associated with the development of diabetes-related complications [5].”
BackgroundAttaye, I., Bird, J. K., Nieuwdorp, M., Gül, S., Seegers, J. F. M. L., Morrison, S. C., Hofkens, S., Herrema, H., Bui, T. P. N., Puhlmann, M.-L., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2504115 · Cited by 22
Carbone, F., Meessen, J. M. T. A., Magnoni, M., Andreini, D., Maggioni, A. P., Latini, R., & Montecucco, F. (2022) · Cells · doi:10.3390/cells11040669 · Cited by 15
Prediabetes: never too early to intervene
Bailey, C. J. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00152-3 · Cited by 13
Timsina, R., Hazen, P. G., Trossi‐Torres, G., Khadka, N. K., Kalkat, N., & Mainali, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031923 · Cited by 13
“…are the primary source of worldwide blindness today [1,2] and are believed to be a multifactorial process involving genetic and environmental factors that can be influenced by age [3,4], diabetes [5–12], corticosteroid use [13–16], vitrectomy [17,18], and hyperbaric oxygen treatment [19–21].”
BackgroundFadhilah, S., Rusliani, D. M., Nuryati, A., & Suryantara, B. (2025) · Room of Civil Society Development · doi:10.59110/rcsd.537 · Cited by 12
“Disfungsi endotel dan remodeling matriks ekstraseluler (ECM) mendorong progresi dari normoglikemia menjadi prediabetes hingga diabetes (Lawal et al., 2020).”
An Expert Group Consensus Statement on “Approach and Management of Prediabetes in India”
Das, A. K., Mohan, V., Ramachandran, A., Kalra, S., Mithal, A., Sahay, R. K., TIWASKAR, M. H., Das, S., Baruah, M. P., Jacob, J. J., et al. (2022) · Journal of the Association of Physicians of India · doi:10.5005/japi-11001-0162 · Cited by 12
Yanto, T. A., Vatvani, A. D., Hariyanto, T. I., & Suastika, K. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103069 · Cited by 12
Family Involvement to Stop the Conversion of Prediabetes to Diabetes
Prakoso, D. A., Mahendradhata, Y., & Istiono, W. (2023) · Korean Journal of Family Medicine · doi:10.4082/kjfm.23.0019 · Cited by 11
“30) Currently, the Food and Drug Administration has not granted approval for any pharmacotherapy treatment options to control prediabetes or prevent disease progression to diabetes.”
BackgroundInfluentialHazen, P. G., Trossi‐Torres, G., Timsina, R., Khadka, N. K., & Mainali, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031936 · Cited by 10
“Previous studies have found both diabetes and prediabetes to be related to the development of cataracts, with prediabetes resulting in the same effects but less severe than the lens changes seen with diabetes [90].”
BackgroundLim, B. S. Y., Chen, M., Li, H., & Li, L. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16442 · Cited by 9
Afsharmanesh, M. R., Mansourian, A. R., Jazi, M. S., Ghaffary, S., Eshghinia, S., Behnampour, N., & Jafari, S. M. (2024) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp-143074 · Cited by 8
Listrikawati, M., Vioneery, D., & Rusmawati, R. (2024) · PubHealth Jurnal Kesehatan Masyarakat · doi:10.56211/pubhealth.v2i3.387 · Cited by 7
Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and Disease
Mineo, C., & Shaul, P. W. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.321545 · Cited by 6
McMullen, B., Duncanson, K., Collins, C. E., & MacDonald‐Wicks, L. K. (2024) · Diabetic Medicine · doi:10.1111/dme.15323 · Cited by 6
Comparison of Lipid Profiles Between Prediabetic and Non-prediabetic Young Adults
Mulla, I. G., Anjankar, A. P., Shinde, A., Pratinidhi, S. A., Agrawal, S. V., Gundpatil, D., & Lambe, S. D. (2024) · Cureus · doi:10.7759/cureus.65251 · Cited by 6
“Prediabetes has been associated with insulin resistance and β -cell dysfunction, both of which can be present even before the changes in blood glucose are detectable [5].”
BackgroundLi, N., Fei, C.-M., Tang, F., Lin, X.-S., Yang, B., Guo, J., Wu, L., Xia, Y., Zhang, C., & Xu, L. (2026) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01193-7 · Cited by 180
“…that could have been reversed through timely behavioral modification to progress unchecked [59–62], ultimately creating a synergistic effect with insulin resistance, MAPK pathway activation, and oxidative stress, to reduce the likelihood of atherosclerotic risk recovery [48, 49, 52–57].”
Taormina, V. M., Eisenhardt, S., Gilbert, M. P., Poynter, M. E., Kien, C. L., & Kraft, J. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.02.005 · Cited by 5
Lipid and Cholesterol Peroxidation Leads to α-Crystallin Membrane Aggregation and Cataract Formation
Khadka, N. K., Hazen, P., Akinola, O., Pu, X., & Mainali, L. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.12.8 · Cited by 5
Srivastava, K., Rathod, H. K., Borgaonkar, C. A., Rathi, M. A., Akhil, R., & Sujanyal, S. A. (2024) · Cureus · doi:10.7759/cureus.68635 · Cited by 4
“Prediabetes increases the risk of these complications, thereby contributing substantially to healthcare expenditures [14].”
BackgroundThe Natural History of Prediabetes and Cardiovascular Disease in the Pediatric Population
Accacha, S. D., Barillas, J., Gabriel, L., Srivastava, A., Gulkarov, S., Apsan, J., Leon, J. D., & Reiss, A. B. (2026) · Biomedicines · doi:10.3390/biomedicines14010198 · Cited by 4
“Prediabetes is characterized by increased lipolysis, which incites hepatic glucose over-production, insulin resistance, β -cell dysfunction, inflammation, and impaired incretin effect [179,180].”
Huang, Q., Zhong, Q., Zeng, Y., Li, Y., Wiley, J. A., Wang, M. P., Chen, J., & Guo, J. (2024) · JMIR mhealth and uhealth · doi:10.2196/47837 · Cited by 4
Fundoiano-Hershcovitz, ., ASHER, I. B., Kantor, H., Rahmon, S., Ritholz, M. D., Horwitz, D. L., Manejwala, O., & Goldstein, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1446405 · Cited by 3
“This knowledge can aid in risk strati fi cation and personalized interventions to prevent diabetes progression (61, 62).”
BackgroundKunyiha, N., Adan, R., Ngugi, R., Odhiambo, J., & Sokwalla, S. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01581-7 · Cited by 3
“Some individuals with IGT were observed to revert to Normal glucose tolerance (NGT) with intensive lifestyle changes, which target weight loss, as well as changes in dietary habits and physical activity [56].”
Association between central thyroid hormone sensitivity and prediabetes: Tehran thyroid study
Mehran, L., Honarvar, M., Tohidi, M., Adib, M., Azizi, F., & Amouzegar, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1534058 · Cited by 3
Tripathi, P., Tiwari, D., KADAM, N. S., VYAWAHARE, A. R., Sharma, B., Kathrikolly, T., GANLA, M. H., & Saboo, B. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/6172692 · Cited by 3
“This aligns with the existing evidence on the 12 Journal of Diabetes Research potential of lifestyle interventions to prevent or delay T2D onset in prediabetic individuals [20, 29, 30].”
Pre-COPD: Impact on prevention, detection, and treatment
Bosma, C. B., Labaki, W. W., & Han, M. K. (2025) · La Presse Médicale · doi:10.1016/j.lpm.2025.104316 · Cited by 3
“Pre-diabetes shares some pathophysiologic mechanisms with diabetes mellitus, but the presence of pre-diabetes does not guarantee progression to diabetes mellitus [10,11].”
Suleman, S., Huang, Y., Jensen, R. T., Poggi, A. I., Christensen, S. B., Fraulund, M. M., Anderson, L. V., Stinson, S. E., Fonvig, C. E., Pedersen, O. B., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae882 · Cited by 3
Tao, X., Guan, Z., Qu, J., Sun, Q., Xiao, Y., Li, Z., Ma, N., Lin, X., Wen, G., Zheng, H., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07582-8 · Cited by 2
“A paired Wilcoxon signed-rank test comparing edge-wise variance between groups yielded p 0.001, indicating significantly higher variability in pre-diabetes metabolically active state [30 ].”
InfluentialDigital Technology in the Management and Prevention of Diabetes
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5649-8 · Cited by 2
Japar, K. V., Hariyanto, T. I., Hamzah, D. V., Prasetya, I. B., & Suastika, K. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10449-x · Cited by 2
“…criteria for diagnosis of prediabetes specified by the American Diabetes Association (ADA) are as follows: (1) fasting blood sugar (FBS) ranging from 100 to 125 mg/dL; (2) 2-h post-prandial blood sugar or oral glucose tolerance test (OGTT) ranging from 140 to 199 mg/dL; (3) HbA1c 5.7 to 6.4% [1].”
InfluentialPrediabetes y su complejo espectro como un reto en la práctica clínica diaria
Rodulfo, J. I. A., Colarossi, G. J. M., Marchan, A., & Aure, G. (2023) · Revista Científica CMDLT · doi:10.55361/cmdlt.v16i.251 · Cited by 1
“2022; 16(1): e-221251 Ciencias Clínicas: Revisión de la Literatura”
BackgroundInfluentialAntunes, D. E., dos Santos, D. F., Thomazelli, J. A., Leite, C. M., & Goulart, I. M. B. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012298 · Cited by 1
“Before diabetes onset and hyperglycemia, pre-diabetes, marked by impaired glucose tolerance (IGT) and/or fasting glucose, occurs [8].”
BackgroundBeena, B., Devasia, S., Stephena, P. S., Sriraam, V. T., Madhavan, S., & Kailas, A. P. (2025) · Next research. · doi:10.1016/j.nexres.2025.100700 · Cited by 1
Kalkat, N., Trossi‐Torres, G., Hazen, P. G., & Mainali, L. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110724 · Cited by 1
Bhatt, S. P., Khurana, A., Pandey, S., & Misra, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1740628 · Cited by 1
“Chronic low grade in fl ammation, increased oxidative stress damage DNA at the telomeric region (8) and impaired glucose and lipid metabolism (9) lead to ageing of the cellular structures, including telomeres.”
Annemans, L., Johansson, E., Spaepen, E., van Hest, N., Grist, J., Zimner‐Rapuch, S., & Wilding, J. P. H. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2646079 · Cited by 1
Cardiac structure and function across the continuum of glucose metabolism
Grönlund, T., Kaikkonen, K., Junttila, J. M., Ukkola, O. H., Kerkelä, R., Huikuri, H. V., & Tulppo, M. P. (2025) · Physiological Reports · doi:10.14814/phy2.70429 · Cited by 1
“Because CVDs and type 2 diabetes share common modifiable behavioral risk factors, such as diet, exercise, smoking, and alcohol use (Lawal et al., 2020), even earlier interventions and preventive measures are crucial for reducing the overall disease burden of these interlinked diseases (Ong et al.,…”
Kandukuri, E., Josephine, A., Anitha, G., Varalakshmi, S., Ilangovan, R., Moovendhan, M., P, R. P., Ramachandran, R., Thomas, P., & Dinesh Roy, D. (2025) · Research Square · doi:10.21203/rs.3.rs-7218746/v1 · Cited by 1
The Roles of Nigella Sativa Seed Extract (NSSE) or Powder (NSSP) on Metabolic SyndromePreprint
Amin, M. R., Amin, R., Islam, M. S., Amin, R., & Sultana, H. (2025) · doi:10.14293/pr2199.002170.v1 · Cited by 1
مقدمات داء السكري: حالة عالية الخطورة للإصابة بالمرض
عابدين, ح. ع. ح., الويفة, ع. ا., & يونس, م. ا. م. (2022) · Journal of Pure & Applied Sciences · doi:10.51984/jopas.v21i3.2392
Optimizing Prediabetes Diagnosis Through Knowledge-Based Systems
Rohajawati, S. (2024) · Asian Journal of Engineering Social and Health · doi:10.46799/ajesh.v3i2.244
Study of subclinical chronotropic response to acute exercise in children of type 2 diabetic parents
Suchitra, N., Jain, M., & Dayananda, G. (2024) · National Journal of Physiology Pharmacy and Pharmacology · doi:10.5455/njppp.2024.14.02060202414022024
Afifah, A., Citrawati, M., Thadeus, M. S., & Widyawardani, N. (2024) · World Nutrition Journal · doi:10.25220/wnj.v08.i1.0011
Joshi, R. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i3s.3070
Prediabetes: A Review of Current Trends
Bineesh, C. P. (2024) · Journal of Diabetes Research Review & Reports · doi:10.47363/jdrr/2024(6)191
Managing Heart Disease in Persons with Diabetes
McCrea, D. L. (2024) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2024.10.001
Proportional Hazards Model for Predictors of Type 2 Diabetes Mellitus among the Elderly
Tumurang, M. N., & Lalangpuling, I. E. (2024) · Journal of Liaquat University of Medical & Health Sciences · doi:10.22442/jlumhs.2024.01181
Assessing the Awareness of Prediabetes and Its Risk Factors among medical students
Pokhrel, P., Thangamuthu, G., Ganicius, D. R. P., Yahya, F., & Gunasekaran, S. (2025) · Eurasian Journal of Scientific and Multidisciplinary Research · doi:10.63666/ejsmr.1694-9013.1.i.2025.20
Basaka, L., Palmisano, C., & Webber‐Ritchey, K. J. (2025) · Journal of Community Health Nursing · doi:10.1080/07370016.2025.2517677
“…people with prediabetes, the first-line treatments include lifestyle interventions focused on healthy eating and increased physical activity and/or pharmacological intervention such as taking medications such as metformin or thiazolidinediones (Echouffo-Tcheugui et al., 2023; Lawal et al., 2020).”
Validation and Reliability of the Coping Instrument in Prediabetes: Exploratory Analysis
Arteaga, G. C. (2025) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2025.60.009411
The Relationship of Risk Factors to Incidence Prediabetes Young Age Groups
Seno, H. N. H., Savitri, A. A., Setiawan, E. K., Setiawan, E. K., & Hendrianingtyas, M. (2025) · Contagion Scientific Periodical Journal of Public Health and Coastal Health · doi:10.30829/contagion.v7i2.24117
“Patients with prediabetes can experience heart disease before developing diabetes (Lawal et al., 2020).”
PATIL, S. M., Singla, S., Bagri, S. A., Shah, T., DBRITTO, S. N., Patil, A., Muley, A. G., Ansari, A., Singh, M., Kolhe, C., et al. (2025) · doi:10.5005/jodec-11035-0004
Amin, M. R., Islam, M. S., & Sultana, H. (2025) · doi:10.14293/pr2199.002385.v1
Increasing awareness and referral of diabetes prevention program in the hospital setting
Tsao, H.-L. (2022) · Montana State University ScholarWorks (Montana State University)
Macas Sarmiento, M. D., & Jácome Morejón, D. M. (2024) · Repositorio Institucional (Universidad de Cuenca)
ASSESSING RESPONSES TO SHORT-TERM GLYCEMIC VARIABILITY IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS
Barrett, K. (2024) · MacSphere (McMaster University) · doi:10.71548/8989
OXIDATIVE DNA DAMAGE AND METABOLIC RISK FACTORS IN PREDIABETES: A CASE-CONTROL STUDY IN DUHOK, IRAQ
AHMED, D. I., & Mahmoud, H. (2025) · Duhok Medical Journal · doi:10.31386/dmj.2025.19.2.10
Jawamis, A., Al-Domi, H. A., & Sarayreh, N. A. (2026) · Nutrition · doi:10.1016/j.nut.2026.113119
Prevalence and Risk Factors of Diabetes and Prediabetes: A Population-Based Survey
Hussein, N. R., Mohammed, W. A. E. S., Musa, D. H., Abozait, H. J., Naqid, I. A., Majed, H. S., Aldoski, Z. S. A., Haji, R. S., Mohammed, H. H., Hito, L. S., et al. (2026) · Galician Medical Journal · doi:10.21802/e-gmj2026-a05
Jokar, M., Ebadi, A., Momenan, A. A., Yousefi, M. S., & Zandi, M. (2026) · Nursing Open · doi:10.1002/nop2.70446
Iseme, R. A., Muia, A. M., Shabani, J. S., Mucheru, S. G., Gathu, C., Gitonga, E., Mutisya, R., Kioko, P. M., Safipour, J., & Witthöft, C. M. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113214
Roisné-Hamelin, G. (2024) · theses.fr (ABES) · doi:10.70675/006069a1zb2b5z45e8zbe4fz5af5e3b6e229
Constantinescu, D. S., Costello, J. P., Samineni, A. V., & D’Apuzzo, M. R. (2026) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1177/15563316261443297
“24-27 When coupled with the body’s baseline physiologic stress response to surgery, prediabetes likely predisposes patients to increased rates of postoperative complications after TKA.”
InfluentialSimanjuntak, O. P., & Lubis, A. M. (2026) · Jurnal Penyakit Dalam Indonesia · doi:10.7454/jpdi.v13i1.1763
Helm, M. M., Buccini, G., Schilling, B. K., Lindsay, A. R., & Basu, A. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2667410
“Finally, as a precursor to T2DM, pre-DM follows a similar pathway with insulin resistance and β-cell dysfunction resulting from disrupted insulin signaling because of proinflammatory cytokines, oxidative stress, and adipose tissue dysfunction (Lawal et al. 2020).”
Glycogen drives the sensory activation of POMC neurons
Gómez-Valadés, A. G., Meseguer, D., Varela, L., Lienhard, G., Fernández, U., Vidal-Itriago, A., Toledo, M., Eyre, E., Laudo, B., Díaz-Castro, F., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01535-7
“Prediabetes, the prelude to the development of diabetes, is a pathophysiological state that embodies an increased risk of disease progression 49 .”
Assessment of Neudesin Serum Levels in Pre-Diabetes and Newly Diagnosed Type 2 Diabetes Mellitus
Haleem, S. A. A., Hamzah, M. I., Khudhai, M. S., & Deli, E. Q. (2026) · Iraqi journal of Medical Sciences · doi:10.22578/6f43y497
“These observations align with the growing emphasis on sensitive biomarkers to enable early intervention in diabetes management (18) .”
Mzimela, N. C. (2024) · ResearchSpace (University of KwaZulu-Natal)
Wang, L., Yan, J., Yu, J., Xi, D., Wang, Y., Li, Q., Zhou, F., Liu, Y., Luo, Z., Sun, J., et al. (2026) · Food Science and Human Wellness · doi:10.26599/fshw.2026.9251139
Sestrin-2: a new biomarker for type 2 Diabetes Mellitus and Insulin resistance
Tyagi, S., Nagtilak, S., & Parashar, P. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-02008-0
“Such assessment may be particularly valuable in populations at increased risk for insulin resistance and related cardiovascular complications [ 8 ].”
Commendatore, V., Debiaggi, C., Flores, L. E., Forte, M. N., y colab., O. B. F., FRECHTEL, G., González, C. D., Lorenzo, O. G., Marcucci, G., Hecker, A. A. M., et al. (2026) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v60i2.1361
Mbae, U. K., Kyallo, F., Othoo, D. A., Ndungu, Z. W., Kiage, B. N., & Were, V. (2026) · Frontiers in Epidemiology · doi:10.3389/fepid.2026.1807836
“Type 2 diabetes damages vital organs, including the retina, liver, and kidneys (38, 39).”
Umeizudike, K. A., Olayiwola, O., Ogundana, A. C., Räisänen, I. T., Nwhator, S. O., Alli, B. Y., Ayanbadejo, P. O., Fasanmade, O. A., & Sorsa, T. A. (2026) · Oral Diseases · doi:10.1111/odi.70481
Investigation of genetic & environmental factors for glycemic status: a family-based study
FERDOS, S. N. (2026) · eScholarship (California Digital Library)
ZAFIRAH, A. N., & Yamani, L. N. (2026) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.2026.17659
Nguyễn, H. T., Nguyễn, H. Q. T., & Nhung, D. T. (2025) · Vietnam Journal of Diabetes and Endocrinology · doi:10.47122/vjde.2024.73.6
Ding, C., 高雅文, & Taylor, R. (2026) · Research Square · doi:10.21203/rs.3.rs-11064428/v1
Ezinne, N. E., Agho, K., Doyle, K., & Osuagwu, U. L. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005876
Metadata
- Authors
- Lawal, Y., Bello, F., & Kaoje, Y. S.
- Affiliations
- Federal Medical Centre (NG)
- Ahmadu Bello University Teaching Hospital (NG)
- Corresponding author
- Lawal, Yakubu
- ORCID
- Lawal, Yakubu
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-10-01
- Volume
- 38
- Issue
- 4
- Pages
- 328-338
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- PMC
- PMC7566925
- OpenAlex
- W3026718593
- Cited by
- 61
- References
- 88
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 17 · 2023: 7 · 2022: 5
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Clinical Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, pathophysiology, diabetes risk, complications, treatment, early intervention, evidence-based treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.